The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Mar. 17, 2026

Filed:

Dec. 18, 2020
Applicants:

The Regents of the University of California, Oakland, CA (US);

Alessa Therapeutics, Inc., San Francisco, CA (US);

Inventors:

Carlos Schuler, San Francisco, CA (US);

Maithili Rairkar, San Francisco, CA (US);

Pujan Desai, Oakland, CA (US);

Maxime Daud, San Francisco, CA (US);

Maxime D. Rappaport, San Francisco, CA (US);

Pamela Munster, San Francisco, CA (US);

John Maroney, San Francisco, CA (US);

Margaret Mclaughlin, San Francisco, CA (US);

Tobias H. Casab, San Francisco, CA (US);

Keith Hall, San Francisco, CA (US);

Scott Thomas, San Francisco, CA (US);

Assignees:

The Regents of the University of California, Oakland, CA (US);

Alessa Therapeutics, Inc., San Francisco, CA (US);

Attorneys:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 31/277 (2006.01); A61K 9/00 (2006.01); A61K 31/275 (2006.01); A61K 47/34 (2017.01); A61M 31/00 (2006.01); A61P 13/08 (2006.01); A61P 35/00 (2006.01);
U.S. Cl.
CPC ...
A61K 31/277 (2013.01); A61K 9/0024 (2013.01); A61K 9/0034 (2013.01); A61K 31/275 (2013.01); A61K 47/34 (2013.01); A61M 31/002 (2013.01); A61P 13/08 (2018.01); A61P 35/00 (2018.01);
Abstract

Provided herein are drug implants comprising a therapeutically active agent for the treatment of disease in a subject. In some cases, the drug implant may comprise a polymer matrix and a therapeutically active agent disposed therein. Additionally, provided are methods for manufacturing the drug implants and methods of treating diseases with the implants. In some cases, the drug implant may comprise bicalutamide, e.g., for use in the treatment of prostate cancer.


Find Patent Forward Citations

Loading…